Critical Illness Polyneuropathy

From WikiMD's Food, Medicine & Wellness Encyclopedia

Critical Illness Polyneuropathy (CIP) is a severe condition that affects the peripheral nerves of patients who are critically ill, particularly those in intensive care units (ICUs). It is characterized by the development of weakness and sensory deficits in the extremities, which can significantly impact the recovery process and prolong the duration of mechanical ventilation and ICU stay. This article aims to provide a comprehensive overview of CIP, including its pathophysiology, clinical presentation, diagnosis, management, and prognosis.

Pathophysiology[edit | edit source]

The exact mechanism underlying CIP is not fully understood, but it is believed to involve a combination of factors related to critical illness, such as systemic inflammatory response, microvascular alterations, and metabolic disturbances. These factors can lead to axonal degeneration and demyelination of peripheral nerves. Sepsis and multiorgan failure are particularly associated with the development of CIP, suggesting a role for systemic inflammation and endothelial dysfunction in its pathogenesis.

Clinical Presentation[edit | edit source]

Patients with CIP typically develop symptoms while still in the ICU, although the condition may not be recognized until attempts are made to wean the patient from mechanical ventilation. The primary manifestation is a profound weakness that is more pronounced distally than proximally. Sensory deficits, though less common, can occur and usually involve a loss of deep tendon reflexes. Autonomic dysfunction may also be present.

Diagnosis[edit | edit source]

The diagnosis of CIP is primarily clinical, supported by electrophysiological studies. Nerve conduction studies (NCS) and electromyography (EMG) are essential for confirming the diagnosis, showing evidence of axonal polyneuropathy. It is important to differentiate CIP from other conditions that can cause weakness in critically ill patients, such as critical illness myopathy (CIM) or combined CIP/CIM.

Management[edit | edit source]

Management of CIP involves addressing the underlying critical illness and providing supportive care. Early mobilization and physical therapy are crucial for preventing muscle atrophy and promoting recovery. Nutritional support and optimization of metabolic parameters are also important. There is no specific pharmacological treatment for CIP, but pain management and treatment of autonomic symptoms may be necessary.

Prognosis[edit | edit source]

The prognosis of CIP varies, with some patients experiencing complete recovery and others having persistent deficits. Factors associated with a poorer prognosis include the severity of the initial illness, the presence of sepsis, and prolonged ICU stay. Early recognition and intervention are key to improving outcomes.

See Also[edit | edit source]

This article is a stub.

Help WikiMD grow by registering to expand it.
Editing is available only to registered and verified users.
About WikiMD: A comprehensive, free health & wellness encyclopedia.


Navigation: Wellness - Encyclopedia - Health topics - Disease Index‏‎ - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes

Search WikiMD

Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro) available.
Advertise on WikiMD

WikiMD is not a substitute for professional medical advice. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.

Contributors: Prab R. Tumpati, MD